IP Library Granted Patent US 9,309,208
Granted Patent B2
US 9,309,208 · App. 13/849,339 · Granted Apr 12, 2016

Methods of making and using thioxothiazolidine and rhodanine derivatives as HIV-1 and JSP-1 inhibitors

Inventors: Edward R. Biehl (Dallas, TX); Sukanta Kamila (Dallas, TX); Ted M. Dawson (Baltimore, MD)
Assignees: Southern Methodist University; Johns Hopkins University
C07D277/34C07D277/62C07D417/06C07D417/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,309,208
App. No.
13/849,339
Granted
Apr 12, 2016
Kind
B2
Abstract

The present invention provides methods of making and using 5-(2-(indol-3-yl)-2-oxoethylidene)-3-phenyl-2-thioxothiazolidin-4-one derivatives having HIV-1 or JSP-1 inhibitory activity.

Claims (3)

1. A thioxothiazolidin compound of formula (I):

wherein R 1 , R 2 , R 3 and R 4 are independently selected from the group consisting of hydrogen, halo, alkyl, aryl, hydroxyl, alkoxyl, aryloxyl, aralkoxyl, cyano, nitro, alkylcarbamido, arylcarbamido, dialkylcarbamido, diarylcarbamido, alkylarylcarbamido, alkylthiocarbamido, arylthiocarbamido, dialkylthiocarbamido, diarylthiocarbamido, alkylarylthiocarbamidb, amino, alkylamino, arylamino, dialkylamino, diarylamino, arylalkylamino, aminocarbonyl, alkylaminocarbonyl, arylaminocarbonyl, dialkylaminocarbonyl, diarylaminocarbonyl, arylalkylamino-carbonyl, alkylcarbonyloxy, arylcarbonyloxy, carboxyl, alkoxycarbonyl, aryloxycarbonyl, sulfo, alkylsulfonylamido, arylsulfonylamido, alkylsulfonyl, arylsulfonyl, alkylsulfinyl, arylsulfinyl and heteroaryl.

2. A thioxothiazolidin compound is selected from (Z)-5-(2-(1H-indol-3-yl)-2-oxoethylidene)-3-phenyl-2-thioxothiazolidin-4-one; (Z)-5-(2-(1H-indol-3-yl)-2-oxoethylidene)-2-thioxo-3-p-tolylthiazolidin-4-one; (Z)-5-(2-(1H-indol-3-yl)-2-oxoethylidene)-3-(3,4-dimethylphenyl)-2-thioxothiazolidin-4-one; (Z)-5-(2-(5-methoxy-1H-indol-3-yl)-2-oxoethylidene)-2-thioxo-3-p-tolylthiazolidin-4-one; (Z)-5-(2-(1H-indol-3-yl)-2-oxoethylidene)-3-(4-methoxyphenyl)-2-thioxothiazolidin-4-one; (Z)-5-(2-(5-methoxy-1H-indol-3-yl)-2-oxoethylidene)-3-(4-methoxyphenyl)-2-thioxothiazolidin-4-one; (Z)-5-(2-(5-methoxy-1H-indol-3-yl)-2-oxoethylidene)-3-phenyl-2-thioxothiazolidin-4-one; (Z)-4-(5-(2-(5-methoxy-1H-indol-3-yl)-2-oxoethylidene)-4-oxo-2-thioxothiazolidin-3-yl)benzonitrile; (Z)-4-(5-(2-(1H-indol-3-yl)-2-oxoethylidene)-4-oxo-2-thioxothiazolidin-3-yl)benzonitrile; (Z)-5-(2-(5-chloro-1H-indol-3-yl)-2-oxoethylidene)-3-phenyl-2-thioxothiazolidin-4-one; (Z)-5-(2-(1H-indol-3-yl)-2-oxoethylidene)-3-(benzo[d]thiazol-6-yl)-2-thioxothiazolidin-4-one; (Z)-5-(2-(1H-indol-3-yl)-2-oxoethylidene)-3-(benzo[d]thiazol-6-yl)-2-thioxothiazolidin-4-one; (Z)-3-(2-(3-(benzo[d]thiazol-6-yl)-4-oxo-2-thioxothiazolidin-5-ylidene)acetyl)-1H-indole-5-carbonitrile; (Z)-5-(2-(1H-indol-3-yl)-2-oxoethylidene)-3-(3,5-dibromo-4-hydroxyphenyl)-2-thioxothiazolidin-4-one; (Z)-5-(2-(1H-indol-3-yl)-2-oxoethylidene)-3-(3,5-dichloro-4-hydroxyphenyl)-2-thioxothiazolidin-4-one; (Z)-3-(3,5-dibromo-4-hydroxyphenyl)-5-(2-(5-methoxy-1H-indol-3-yl)-2-oxoethylidene)-2-thioxothiazolidin-4-one; or (Z)-3-(3,5-dichloro-4-hydroxyphenyl)-5-(2-(5-methoxy-1H-indol-3-yl)-2-oxoethylidene)-2-thioxothiazolidin-4-one.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jul 1, 2016
From: JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039239/0330 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2013
From: DAWSON, TED M.
To: JOHNS HOPKINS UNIVERSITY
Reel/Frame 031139/0871 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2013
From: BIEHL, EDWARD R.; KAMILA, SUKANTA
To: SOUTHERN METHODIST UNIVERSITY
Reel/Frame 030074/0256 →
Continuity (2)
Provisional Application 61614563 · Mar 23, 2012
Related Publication 20130253021A1 · Sep 26, 2013